HEATON Healthcare Group to Participate in CPHI Frankfurt 2025

HEATON Healthcare Group has announced its participation in CPHI Frankfurt 2025, one of the world’s leading pharmaceutical industry events, where innovation meets global opportunity.

With more than 20 years of expertise in the pharmaceutical sector, HEATON Healthcare Group has built a strong reputation for quality, innovation, and enduring partnerships. The company operates across the Czech Republic, Slovakia, Germany, Romania, and Singapore, leveraging deep market insights to deliver exceptional healthcare solutions.

Its diverse portfolio spans gynecology, urology, diabetology, critical care, and nephrology, addressing key areas of patient care. At CPHI Frankfurt, HEATON Healthcare Group will spotlight its high-quality OTC Women’s Health and nephrologyproducts, aiming to introduce them to new international markets.
The company is actively seeking strategic partnerships to expand its global presence and welcomes opportunities to collaborate with like-minded innovators. In addition to market expansion, HEATON is open to adding new productsto complement its existing portfolio, further strengthening its commitment to patient health worldwide.

Visitors can meet the HEATON Healthcare Group team during the event to explore partnership possibilities and discover how the company’s dedication to quality and innovation can benefit healthcare systems across the globe.

Schedule a meeting

Portfolio